Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Baxter
McKesson
Express Scripts
Johnson and Johnson

Last Updated: November 30, 2022

Metoprolol tartrate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for metoprolol tartrate and what is the scope of freedom to operate?

Metoprolol tartrate is the generic ingredient in two branded drugs marketed by Novartis, Am Regent, Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hikma Farmaceutica, Hospira, Luitpold, Sandoz Inc, Steriscience, Watson Labs, Validus Pharms, Alembic Pharms Ltd, Apothecon, Aurobindo Pharma, Chartwell Rx, Heritage Pharma, Ipca Labs Ltd, Mylan, Purepac Pharm, Renata, Rubicon, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, and Youngtech Pharms Inc, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for metoprolol tartrate. Forty-seven suppliers are listed for this compound.

Drug Prices for metoprolol tartrate

See drug prices for metoprolol tartrate

Drug Sales Revenue Trends for metoprolol tartrate

See drug sales revenues for metoprolol tartrate

Recent Clinical Trials for metoprolol tartrate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The New York Community TrustPhase 4
Weill Medical College of Cornell UniversityPhase 4
National Institute on Aging (NIA)Phase 4

See all metoprolol tartrate clinical trials

Pharmacology for metoprolol tartrate

US Patents and Regulatory Information for metoprolol tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs METOPROLOL TARTRATE metoprolol tartrate INJECTABLE;INJECTION 074032-001 Dec 21, 1993 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sun Pharm Inds Inc METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 076670-001 Jan 15, 2004 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Watson Labs METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 074217-001 May 27, 1994 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Chartwell Rx METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 073289-001 Mar 25, 1994 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Validus Pharms LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-002 Approved Prior to Jan 1, 1982 AB RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Youngtech Pharms Inc METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 208955-002 Feb 5, 2020 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hikma METOPROLOL TARTRATE metoprolol tartrate INJECTABLE;INJECTION 076495-001 Jul 7, 2003 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for metoprolol tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis LOPRESSOR metoprolol tartrate INJECTABLE;INJECTION 018704-001 Mar 30, 1984 See Plans and Pricing See Plans and Pricing
Validus Pharms LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Validus Pharms LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Validus Pharms LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Validus Pharms LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Novartis LOPRESSOR metoprolol tartrate INJECTABLE;INJECTION 018704-001 Mar 30, 1984 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Merck
AstraZeneca
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.